Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

ClinicalTrials.gov ID: NCT04340362

Public ClinicalTrials.gov record NCT04340362. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Open-label, Single-arm, 2-Part Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

Study identification

NCT ID
NCT04340362
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vertex Pharmaceuticals Incorporated
Industry
Enrollment
16 participants

Conditions and interventions

Interventions

  • VX-147 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 7, 2020
Primary completion
Nov 10, 2021
Completion
Dec 8, 2021
Last update posted
Sep 23, 2025

2020 – 2021

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
University of Alabama at Birmingham - The Kirklin Clinic Birmingham Alabama 35294
California Institute of Renal Research San Diego California 92123
The George Washington University Medical Faculty Associates - Kidney Disease & Hypertension Washington D.C. District of Columbia 20037
Howard University Hospital Washington D.C. District of Columbia 20060
Kidney and Hypertension Specialists of Miami Miami Florida 33150
Florida Premier Research Institute Winter Park Florida 32789
Morehouse School of Medicine, Grady Memorial Hospital Atlanta Georgia 30310
Children's Healthcare of Atlanta Atlanta Georgia 30329
Georgia Nehphrology Lawrenceville Georgia 30046
Central Georgia Kidney Specialists PC Macon Georgia 31201
Renal Associates of Baton Rouge Baton Rouge Louisiana 70808
Ochsner Medical Center - New Orleans New Orleans Louisiana 70121
Boston Medical Center Boston Massachusetts 02118
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Renal and Transplant Associates of New England, PC Springfield Massachusetts 01107
Paragon Health, PC d/b/a Nephrology Center, PC Kalamazoo Michigan 49007
Nephrology and Hypertension Associates, LTD Tupelo Mississippi 38801
St Louis Kidney Care St Louis Missouri 63136
Nevada Kidney Disease and Hypertension Centers Las Vegas Nevada 89106
SUNY Downstate Brooklyn New York 11203
Urban Family Practice Buffalo New York 14201
Icahn School of Medicine at Mount Sinai New York New York 10029
UNC Kidney Center Division of Nephrology & Hypertension Chapel Hill North Carolina 27599
Tryon Medical Partners Charlotte North Carolina 28210
Durham Nephrology Associates, PA Durham North Carolina 27704
Duke University School of Medicine - Duke Molecular Physiology Institute Durham North Carolina 27710
Temple University Hospital Philadelphia Pennsylvania 19140
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224
Medical University of South Carolina Charleston South Carolina 29425
South Carolina Nephrology and Hypertension Center, Inc. Orangeburg South Carolina 29118
Vanderbilt University VU Nashville Tennessee 37232
Prolato Clinical Research Center Houston Texas 77054
Privia Medical Group Houston Texas 77095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04340362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04340362 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →